Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Flier

Showing results (141-150 of 791) with videos related to

Pageof 80
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 12, 2022
Development and design of a diagnostic report to support communication in dementia: Co-creation with patients and care partnersAniek M van Gils, Leonie N C Visser, Heleen M A Hendriksen, et al.
Alzheimer'S Research & Therapy|June 3, 2018
Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's diseaseMadhurima Chatterjee, Marta Del Campo, Tjado H J Morrema, et al.
Clinical Chemistry and Laboratory Medicine|February 24, 2011
Tau and p-tau as CSF biomarkers in dementia: a meta-analysisArgonde C van Harten, Maartje I Kester, Pieter-Jelle Visser, et al.
Neurobiology of Aging|November 29, 2011
Microbleeds relate to altered amyloid-β metabolism in Alzheimer's diseaseJeroen D C Goos, Charlotte E Teunissen, Robert Veerhuis, et al.
Neurobiology of Aging|April 17, 2013
Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activityHanneke de Waal, Cornelis J Stam, Willem de Haan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaintsArgonde C van Harten, Pieter Jelle Visser, Yolande A L Pijnenburg, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 28, 2014
Disturbed phase relations in white matter hyperintensity based vascular dementia: an EEG directed connectivity studyE C W van Straaten, J den Haan, H de Waal, et al.
Alzheimer'S Research & Therapy|April 4, 2023
Experiences of and recommendations on clinical trial design in Alzheimer's disease from the participant's point of view: a mixed-methods study in two clinical trial centers in the NetherlandsLois Ottenhoff, Everard G B Vijverberg, Leonie N C Visser, et al.
European Journal of Heart Failure|August 28, 2007
Brain magnetic resonance imaging abnormalities in patients with heart failureRaymond L C Vogels, Wiesje M van der Flier, Barbera van Harten, et al.
Journal of the American Geriatrics Society|August 31, 2007
Profile of cognitive impairment in chronic heart failureRaymond L C Vogels, Joukje M Oosterman, Barbera van Harten, et al.
Pageof 80

Showing results (141-150 of 791) with videos related to

Sort By:
Pageof 80
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 12, 2022
Development and design of a diagnostic report to support communication in dementia: Co-creation with patients and care partnersAniek M van Gils, Leonie N C Visser, Heleen M A Hendriksen, et al.
Alzheimer'S Research & Therapy|June 3, 2018
Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's diseaseMadhurima Chatterjee, Marta Del Campo, Tjado H J Morrema, et al.
Clinical Chemistry and Laboratory Medicine|February 24, 2011
Tau and p-tau as CSF biomarkers in dementia: a meta-analysisArgonde C van Harten, Maartje I Kester, Pieter-Jelle Visser, et al.
Neurobiology of Aging|November 29, 2011
Microbleeds relate to altered amyloid-β metabolism in Alzheimer's diseaseJeroen D C Goos, Charlotte E Teunissen, Robert Veerhuis, et al.
Neurobiology of Aging|April 17, 2013
Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activityHanneke de Waal, Cornelis J Stam, Willem de Haan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaintsArgonde C van Harten, Pieter Jelle Visser, Yolande A L Pijnenburg, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 28, 2014
Disturbed phase relations in white matter hyperintensity based vascular dementia: an EEG directed connectivity studyE C W van Straaten, J den Haan, H de Waal, et al.
Alzheimer'S Research & Therapy|April 4, 2023
Experiences of and recommendations on clinical trial design in Alzheimer's disease from the participant's point of view: a mixed-methods study in two clinical trial centers in the NetherlandsLois Ottenhoff, Everard G B Vijverberg, Leonie N C Visser, et al.
European Journal of Heart Failure|August 28, 2007
Brain magnetic resonance imaging abnormalities in patients with heart failureRaymond L C Vogels, Wiesje M van der Flier, Barbera van Harten, et al.
Journal of the American Geriatrics Society|August 31, 2007
Profile of cognitive impairment in chronic heart failureRaymond L C Vogels, Joukje M Oosterman, Barbera van Harten, et al.
Pageof 80